Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Genzyme’s Lemtrada™ approved in Canada for treatment of multiple sclerosis
RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence.
"Undiagnosing" multiple sclerosis: The challenge of misdiagnosis in MS.
The little compound that could: how phenytoin changed drug discovery and development.
Early relapses, onset of progression, and late outcome in multiple sclerosis.
A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone
Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy.
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis.
Neuroenhancement through cognitive training and anodal tDCS in multiple sclerosis.
[Diagnosis of multiple sclerosis - the 2010 revision of the McDonald criteria.]
Microvesicles: novel biomarkers for neurological disorders.
Neuromyelitis Optica Following Human Papillomavirus Vaccination.
Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica.
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate.
Complementary and alternative medicine in multiple sclerosis.
Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects with Multiple Sclerosis
The influence of ethnicity on the characteristics of multiple sclerosis: A local population study between Persians and Arabs.
Cancer risk in multiple sclerosis: findings from British Columbia, Canada.
Disrupted balance of T cells under natalizumab treatment in multiple sclerosis.
Managing fatigue in patients with multiple sclerosis.
UVB light attenuates the systemic immune response in CNS autoimmunity.
Santhera enters agreement with Columbia University to investigate additional potential of Catena® in MELAS
CHMP assessment report for Sovrima (International nonproprietary name: idebenone)
Multiple sclerosis and oligodendroglioma: an exceptional association.
A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JC virus testing.

Pages